Delayed adverse reaction to contrast-enhanced CT: A prospective single-center study comparison to control group without enhancement

Radiology

Volumn 255, Issue 3, 2010, Pages 764-771

  Loh, Shaun ^a   Bagheri, Sepideh ^b   Katzberg, Richard W ^a   Fung, Maxwell A ^a,b   Li, Chin Shang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IODIXANOL; IOHEXOL; NONIONIC CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DIZZINESS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PRURITUS; QUESTIONNAIRE; RASH; SKIN BIOPSY; SKIN REDNESS; SKIN SWELLING; STATISTICAL ANALYSIS; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; INCIDENCE; IOHEXOL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUESTIONNAIRES; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77952716347     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10091848     Document Type: Article

References (23)

1. American College of Radiology manual on contrast media, version 6.0. American College of Radiology Web site. http://www.acr.org/. Published May 2008. Accessed October 4, 2009.
2. Panto P, Davies P. Delayed reactions to urographic contrast media. Br J Radiol 1986;59(697):41-44. (Pubitemid 16189683)
3. Bush WH Jr, Lasser EC. Iodinated contrast media for urologic imaging. In: Pollack HM, McClennan BL, eds. Clinical urography. 2nd ed. Philadelphia, Pa : Saunders, 2000.
4. Munechika H, Yasuda R, Michihiro K. Delayed adverse reaction of monomeric contrast media: comparison of plain CT and enhanced CT. Acad Radiol 1998;5(suppl 1 ):S157-S158.
5. Schild HH, Kuhl CK, Hübner-Steiner U, Böhm I, Speck U. Adverse events after unenhanced and monomeric and dimeric contrast-enhanced CT: a prospective randomized controlled trial. Radiology 2006;240(1):56-64. (Pubitemid 43902594)
6. Bertrand P, Delhommais A, Alison D, Rouleau P. Immediate and delayed tolerance of iohexol and ioxaglate in lower limb phlebography: a double-blind comparative study in humans. Acad Radiol 1995;2(8):683-686.
7. McCullough M, Davies P, Richardson R. A large trial of intravenous Conray 325 and Niopam 300 to assess immediate and delayed reactions. Br J Radiol 1989;62(735):260-265. (Pubitemid 19064271)
8. Higashi TS, Katayama M. The delayed adverse reactions of low osmolar contrast media. Nippon Igaku Hoshasen Gakkai Zasshi 1990;50(11):1359-1366.
9. Sortland O, Johansen JG, Oksendal AN, Waaler A. Iopentol in urography: a clinical comparison between iopentol and metrizoate including delayed reactions. Acta Radiol 1992;33(4):368-373.
10. Valentine A, Jakobsen JA, Klaveness AJ. Iopentol (Imagopaque 350) compared with diatrizoate (Urografin 370) in cerebral CT: a clinical trial assessing immediate and late (7 days) adverse events and diagnostic information (visualization quality and Hounsfield unit measurements). Eur Radiol 1997;7(suppl 4):S145-S148.
11. Munechika H, Hiramatsu Y, Kudo S, et al. A prospective survey of delayed adverse reactions to iohexol in urography and computed tomography. Eur Radiol 2003;13(1):185-194. (Pubitemid 36790509)
12. Sutton AGC, Finn P, Grech ED, et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterization. Am Heart J 2001;141(4):677-683.
13. Sutton AGC, Finn P, Campbell PG, et al. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterization. J Invasive Cardiol 2003;15(3):133-138. (Pubitemid 36330935)
14. Vijayalakshmi K, Williams D, Wright RA, et al. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization. J Invasive Cardiol 2004;16(12):707-711.
15. Vijayalakshmi K, Kunadian B, Wright RA, et al. A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iomeprol 350 (Iomeron) in cardiac catheterisation. Eur J Radiol 2007;61(2):342-350.
16. Palmers Y, De Greef D, Grynne BH, Smits J, Put E. A double-blind study comparing safety, tolerability and efficacy of iodixanol 320 mgI/ml and ioxaglate 320 mgI/ml in cerebral arteriography. Eur J Radiol 1993;17(3):203-209.
17. Conroy RM, Bjartveit K, Sheppick A, Long U, Masterson J. Iodixanol in intravenous urography: a comparison of iodixanol 270 mgI/ml, iodixanol 320 mgI/ml and iopamidol 300 mgI/ml (NIOPAM). Clin Radiol 1994;49(5):337-340. (Pubitemid 24146742)
18. Fischbach R, Landwehr P, Lackner K, et al. Iodixanol vs iopamidol in intravenous DSA of the abdominal aorta and lower extremity arteries: a comparative phase-III trial. Eur Radiol 1996;6(1):9-13. (Pubitemid 126460031)
19. Manninen H, Tahvanainen K, Borch KW. Iodixanol, a new non-ionic, dimeric contrast medium in cardioangiography: a double masked, parallel comparison with iopromide. Eur Radiol 1995;5(4):364-370.
20. Skehan SJ, Rasmussen F, Gibney RG, et al. A comparison of a non-ionic dimer, iodixanol with a non-ionic monomer, iohexol in low dose intravenous urography. Br J Radiol 1998;71(849):910-917.
21. Posadas SJ, Pichler WJ. Delayed drug hypersensitivity reactions: new concepts. Clin Exp Allergy 2007;37(7):989-999.
22. Speck U, Böhle F, Krause W, Martin JL, Miklautz H, Schuhmann-Giampieri G. Delayed hypersensitivity to X-ray CM: possible mechanisms and models. Acad Radiol 1998; 5(suppl 1):S162-S165; discussion S166.
23. Latest IMV CT census shows slow-down in the purchase of CT technology. IMV Medical Information Division Web site. http://www.imvinfo.com/user/ documents/content-documents/def-dis/2008-03-21-11-25-43- 706.pdf. Published March 20, 2008. Accessed September 11, 2009.